As was the case in the proposed PFE-AZN deal, there is no way to re-incorporate the acquiring US company in a new country without making the deal taxable; from a tax standpoint, existing MDT shareholders will be deemed to have sold their existing shares of MDT and purchased shares of Medtronic Plc (the newly formed company domiciled in Ireland).
The EPS impact for MDT:
Notably, 15% of the merged company’s sales will derive from emerging markets.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.